Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06145308
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-09-07
Brief Title:
Precision Treatment of RecurrentMetastatic Salivary Gland Carcinoma Guided by Molecular Typing
Sponsor:
Peking Union Medical College
Organization:
Peking Union Medical College
Study Overview
Official Title:
Cancer Hospital Chinese Academy of Medical SciencesNational Cancer Center of China
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with salivary gland carcinoma were divided into groups according to HER2 NTRK AR TROP-2 etc Patients in different groups were given precision targeted therapy or chemotherapy to evaluate the efficacy ORR rate etc and safety of precision neoadjuvant or conversion therapy
Detailed Description:
1 Patients with locally advancedrecurrent or oligometastatic salivary gland carcinoma were divided into groups according to HER2 NTRK AR TROP-2 etc Patients in different groups were given precision targeted therapy or chemotherapy to evaluate the efficacy ORR rate etc and safety of precision neoadjuvant or conversion therapy
2 Patients with locally advancedrecurrent or metastatic salivary gland carcinoma with symptoms and rapid progression who could not tolerate or refuse surgery were divided into groups according to HER2 NTRK AR TROP-2 etc Patients in different groups were given precise targeted therapy or chemotherapy to evaluate the efficacy ORR rate etc and safety of rescue therapy
3 To explore biomarkers related to the efficacy of precision treatment of salivary gland cancer
2 Patients with locally advancedrecurrent or metastatic salivary gland carcinoma with symptoms and rapid progression who could not tolerate or refuse surgery were divided into groups according to HER2 NTRK AR TROP-2 etc Patients in different groups were given precise targeted therapy or chemotherapy to evaluate the efficacy ORR rate etc and safety of rescue therapy
3 To explore biomarkers related to the efficacy of precision treatment of salivary gland cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None